Scott Centea - Net Worth and Insider Trading

Scott Centea Net Worth

The estimated net worth of Scott Centea is at least $412,034 dollars as of 2024-12-28. Scott Centea is the Sr. VP/GM, Global VIT of AngioDynamics Inc and owns about 46,244 shares of AngioDynamics Inc (ANGO) stock worth over $412,034. Details can be seen in Scott Centea's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Centea has not made any transactions after 2021-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Scott Centea

To

Scott Centea Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Centea owns 1 companies in total, including AngioDynamics Inc (ANGO) .

Click here to see the complete history of Scott Centea’s form 4 insider trades.

Insider Ownership Summary of Scott Centea

Ticker Comapny Transaction Date Type of Owner
ANGO AngioDynamics Inc 2023-07-14 SVP/GM & VIT

Scott Centea Latest Holdings Summary

Scott Centea currently owns a total of 1 stock. Scott Centea owns 46,244 shares of AngioDynamics Inc (ANGO) as of October 15, 2021, with a value of $412,034.

Latest Holdings of Scott Centea

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANGO AngioDynamics Inc 2021-10-15 46,244 8.91 412,034

Holding Weightings of Scott Centea


Scott Centea Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Centea has made a total of 1 transactions in AngioDynamics Inc (ANGO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AngioDynamics Inc is the sale of 12,000 shares on October 15, 2021, which brought Scott Centea around $335,040.

Insider Trading History of Scott Centea

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Centea Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott Centea Ownership Network

Ownership Network List of Scott Centea

No Data

Ownership Network Relation of Scott Centea

Insider Network Chart

Scott Centea Owned Company Details

What does AngioDynamics Inc do?

Who are the key executives at AngioDynamics Inc?

Scott Centea is the SVP/GM & VIT of AngioDynamics Inc. Other key executives at AngioDynamics Inc include SVP Quality and Regulatory Warren Jr Nighan , SVP and General Counsel Stephen A Trowbridge , and director & President and CEO James C Clemmer .

AngioDynamics Inc (ANGO) Insider Trades Summary

Over the past 18 months, Scott Centea made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 30,000 shares made by James C Clemmer , a net purchase of 1,700 shares made by Stephen A Trowbridge , and a net purchase of 868 shares made by Warren Jr Nighan .

In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 22,568 shares, with a net purchase of 22,568 shares. During the past 18 months, 0 shares of AngioDynamics Inc (ANGO) were sold and 32,568 shares were bought by its insiders, resulting in a net purchase of 32,568 shares.

AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AngioDynamics Inc Insider Transactions

No Available Data

Scott Centea Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Centea. You might contact Scott Centea via mailing address: C/o Angiodynamics, Inc., 14 Plaza Drive, Latham Ny 12110.

Discussions on Scott Centea

No discussions yet.